1. Local delivery of chemotherapeutic agent in tissue engineering based on gelatin/graphene hydrogel
- Author
-
Esfandyar Askari, Kyong Yop Rhee, Amir Seyfoori, Yasser Zare, Alireza Zahedi, and Seyed Morteza Naghib
- Subjects
Local delivery ,Materials science ,food.ingredient ,Mechanical properties ,02 engineering and technology ,01 natural sciences ,Gelatin ,Biomaterials ,Extracellular matrix ,food ,Tissue engineering ,0103 physical sciences ,medicine ,Doxorubicin ,Viability assay ,010302 applied physics ,Mining engineering. Metallurgy ,Metals and Alloys ,TN1-997 ,021001 nanoscience & nanotechnology ,Controlled release ,Cell aggregation ,Surfaces, Coatings and Films ,Self-healing hydrogels ,Ceramics and Composites ,Biophysics ,Graphene ,0210 nano-technology ,medicine.drug ,3D in vitro tumor models - Abstract
Repairing and replacing of tumor tissues have been grown due to the genetic changes and environmental factors. Conventional cancer therapies apply the systemic approaches for delivery of anticancer agents in which normal and cancer cells are not discriminated. Therefore, the risk of cancer recurrence in the resection site increases. In this paper, we studied a graphene reinforced gelatin hydrogel for tissue engineering and local controlled release of chemotherapeutic agents. Protein-integrated graphene (PIG) synthesized by ultrasonic-supported technique was incorporated into gelatin matrix, where the swelling ratio of hydrogels decreased with increasing the PIG concentration. In hydrogels, doxorubicin (DOX) was released in a controlled and pH-sensitive manner and the release rate was controlled by PIG concentration. The effect of PIG on the controlled release system was detected in MCF-7 cell viability. Moreover, 3D tumor spheroid test studied the extracellular matrix (ECM) and cell aggregation as an in vivo model. Generally, we introduced a novel hydrogel nanocomposite, which is a suitable candidate for post-surgery treatment and localized therapy.
- Published
- 2021